211 related articles for article (PubMed ID: 33893566)
1. Development of Apremilast Solid Dispersion Using TPGS and PVPVA with Enhanced Solubility and Bioavailability.
Yang L; Wu P; Xu J; Xie D; Wang Z; Wang Q; Chen Y; Li CH; Zhang J; Chen H; Quan G
AAPS PharmSciTech; 2021 Apr; 22(4):142. PubMed ID: 33893566
[TBL] [Abstract][Full Text] [Related]
2. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
Goddeeris C; Willems T; Van den Mooter G
Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
[TBL] [Abstract][Full Text] [Related]
3. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
4. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
6. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
7. Characterization, in Vivo and in Vitro Evaluation of Solid Dispersion of Curcumin Containing d-α-Tocopheryl Polyethylene Glycol 1000 Succinate and Mannitol.
Song IS; Cha JS; Choi MK
Molecules; 2016 Oct; 21(10):. PubMed ID: 27763524
[TBL] [Abstract][Full Text] [Related]
8. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study.
Janssens S; Nagels S; Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
Eur J Pharm Biopharm; 2008 May; 69(1):158-66. PubMed ID: 18164929
[TBL] [Abstract][Full Text] [Related]
9. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
Dhumal RS; Biradar SV; Aher S; Paradkar AR
J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability.
Zhang F; Mao J; Tian G; Jiang H; Jin Q
AAPS PharmSciTech; 2022 Jan; 23(1):65. PubMed ID: 35102461
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of solubility and oral bioavailability of manidipine by formation of ternary solid dispersion with d-α-tocopherol polyethylene glycol 1000 succinate and copovidone.
Chamsai B; Limmatvapirat S; Sungthongjeen S; Sriamornsak P
Drug Dev Ind Pharm; 2017 Dec; 43(12):2064-2075. PubMed ID: 28836855
[TBL] [Abstract][Full Text] [Related]
12. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.
Moneghini M; De Zordi N; Solinas D; Macchiavelli S; Princivalle F
Future Med Chem; 2010 Feb; 2(2):237-46. PubMed ID: 21426191
[TBL] [Abstract][Full Text] [Related]
13. Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.
Ha ES; Choo GH; Baek IH; Kim MS
Molecules; 2014 Dec; 19(12):20325-39. PubMed ID: 25486246
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q
Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058
[TBL] [Abstract][Full Text] [Related]
15. Design of mirtazapine solid dispersion with different carriers' systems: optimization, in vitro evaluation, and bioavailability assessment.
Aldeeb RAE; Mahdy MAE; El-Nahas HM; Musallam AA
Drug Deliv Transl Res; 2023 Sep; 13(9):2340-2352. PubMed ID: 36940079
[TBL] [Abstract][Full Text] [Related]
16. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
[TBL] [Abstract][Full Text] [Related]
18. Characterization of curcumin-PVP solid dispersion obtained by spray drying.
Paradkar A; Ambike AA; Jadhav BK; Mahadik KR
Int J Pharm; 2004 Mar; 271(1-2):281-6. PubMed ID: 15129995
[TBL] [Abstract][Full Text] [Related]
19. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
20. Electrosprayed Polymeric Nanospheres for Enhanced Solubility, Dissolution Rate, Oral Bioavailability and Antihyperlipidemic Activity of Bezafibrate.
Sun R; Shen C; Shafique S; Mustapha O; Hussain T; Khan IU; Mehmood Y; Anwer K; Shahzad Y; Yousaf AM
Int J Nanomedicine; 2020; 15():705-715. PubMed ID: 32099359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
